These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24384092)

  • 1. An N-terminal splice variant of human Stat5a that interacts with different transcription factors is the dominant form expressed in invasive ductal carcinoma.
    Tan D; Chen KE; Deng C; Tang P; Huang J; Mansour T; Luben RA; Walker AM
    Cancer Lett; 2014 Apr; 346(1):148-57. PubMed ID: 24384092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
    Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
    Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.
    Fang F; Rycyzyn MA; Clevenger CV
    Endocrinology; 2009 Apr; 150(4):1597-606. PubMed ID: 19036881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer.
    Craig JM; Turner TH; Harrell JC; Clevenger CV
    Endocrinology; 2021 May; 162(5):. PubMed ID: 33589921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of STAT5a signaling in morphine-induced up-regulation of the cyclin D1.
    Guo L; Li H; Liu H; Li C; Li M; Jiang W; He P; Wang S; McNutt MA; Li G
    Biochem Pharmacol; 2009 May; 77(9):1553-60. PubMed ID: 19426693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT5A is regulated by DNA damage via the tumor suppressor p53.
    Mukhopadhyay UK; Cass J; Raptis L; Craig AW; Bourdeau V; Varma S; SenGupta S; Elliott BE; Ferbeyre G
    Cytokine; 2016 Jun; 82():70-9. PubMed ID: 26876578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer.
    Woock AE; Grible JM; Olex AL; Harrell JC; Zot P; Idowu M; Clevenger CV
    Sci Rep; 2021 Jun; 11(1):13506. PubMed ID: 34188118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species.
    Du W; Wang YC; Hong J; Su WY; Lin YW; Lu R; Xiong H; Fang JY
    J Cell Physiol; 2012 Jun; 227(6):2421-9. PubMed ID: 21826656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cells with minimal expression of the JAK/STAT pathway related proteins STAT5a and the prolactin receptor: evidence of an alternate prolactin receptor isoform in breast disease.
    Bratthauer GL; Stamatakos MD; Vinh TN
    Protein Pept Lett; 2010 Jan; 17(1):104-8. PubMed ID: 20214633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-221/222 control luminal breast cancer tumor progression by regulating different targets.
    Dentelli P; Traversa M; Rosso A; Togliatto G; Olgasi C; MarchiĆ² C; Provero P; Lembo A; Bon G; Annaratone L; Sapino A; Falcioni R; Brizzi MF
    Cell Cycle; 2014; 13(11):1811-26. PubMed ID: 24736554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.
    Linher-Melville K; Haftchenary S; Gunning P; Singh G
    Mol Cell Biochem; 2015 Jul; 405(1-2):205-21. PubMed ID: 25896132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.
    Medler TR; Craig JM; Fiorillo AA; Feeney YB; Harrell JC; Clevenger CV
    Mol Cancer Res; 2016 Oct; 14(10):994-1008. PubMed ID: 27358110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch3 restricts metastasis of breast cancers through regulation of the JAK/STAT5A signaling pathway.
    Chen MN; Fang ZX; Wu Z; Bai JW; Li RH; Wen XF; Zhang GJ; Liu J
    BMC Cancer; 2023 Dec; 23(1):1257. PubMed ID: 38124049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies.
    Ginsburg E; Alexander S; Lieber S; Tarplin S; Jenkins L; Pang L; Heger CD; Goldsmith P; Vonderhaar BK
    BMC Cancer; 2010 Dec; 10():678. PubMed ID: 21144038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast.
    Schmid BC; Rudas M; Fabjani G; Speiser P; Kaserer K; Leodolter S; Zeillinger R
    Oncol Rep; 2003; 10(6):1981-5. PubMed ID: 14534730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT5 and prolactin participate in a positive autocrine feedback loop that promotes angiogenesis.
    Yang X; Meyer K; Friedl A
    J Biol Chem; 2013 Jul; 288(29):21184-21196. PubMed ID: 23729680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells.
    Dagvadorj A; Tan SH; Liao Z; Xie J; Nurmi M; Alanen K; Rui H; Mirtti T; Nevalainen MT
    Int J Biochem Cell Biol; 2010 Dec; 42(12):2037-46. PubMed ID: 20854925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT5A modulates gastric cancer progression via upregulation of CD44.
    Wang S; Fan R; Gao H; Ma X; Wu Y; Xing Y; Wang Y; Jia Y
    Genomics; 2023 May; 115(3):110638. PubMed ID: 37196931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.
    Tran TH; Utama FE; Sato T; Peck AR; Langenheim JF; Udhane SS; Sun Y; Liu C; Girondo MA; Kovatich AJ; Hooke JA; Shriver CD; Hu H; Palazzo JP; Bibbo M; Auer PW; Flister MJ; Hyslop T; Mitchell EP; Chervoneva I; Rui H
    Clin Cancer Res; 2018 Dec; 24(24):6355-6366. PubMed ID: 30097435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis.
    Zeng Y; Min L; Han Y; Meng L; Liu C; Xie Y; Dong B; Wang L; Jiang B; Xu H; Zhuang Q; Zhao C; Qu L; Shou C
    Carcinogenesis; 2014 Oct; 35(10):2244-53. PubMed ID: 24925029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.